Peer Navigator Education for Breast Cancer Survivorship
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if peer navigator education, a supportive program led by trained peers, can enhance the quality of life for African American breast cancer survivors. Participants will either join peer-led sessions tailored to their needs or receive educational materials. The trial targets individuals 1-12 months post-treatment for early-stage breast cancer, receiving care through an HMO, and without other major health conditions. As an unphased trial, it offers a unique opportunity to contribute to research that could improve support systems for future breast cancer survivors.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that Peer Navigator Education is safe for breast cancer survivors?
Research has shown that peer navigator education is safe for African American breast cancer survivors. Studies have found this program easy to manage, with no negative effects reported. Participants in these programs experienced benefits such as fewer trauma symptoms and improved emotional well-being. This indicates the program supports survivors without causing harm.12345
Why are researchers excited about this trial?
Unlike traditional breast cancer survivorship care, which often relies on self-driven use of educational materials, the Peer Navigator Education program offers a personalized approach. This treatment is unique because it involves peer navigators who provide tailored support through four sessions, plus a booster session after six months. Researchers are excited about this approach as it aims to enhance patient empowerment and improve outcomes by offering ongoing, personalized guidance, rather than just standard American Cancer Society (ACS) materials alone. This human-centered touch could potentially address the emotional and practical challenges that survivors face, providing a more holistic support system.
What evidence suggests that peer navigator education is effective for improving survivorship care in breast cancer survivors?
Research has shown that education from peer navigators can greatly benefit breast cancer survivors. In this trial, participants in one arm will receive Peer Navigator Education along with ACS materials. One study found that survivors who worked with peer navigators felt more in control, with over 71% feeling confident about managing their care. They also experienced fewer trauma symptoms, particularly feeling less on edge, which improved their emotional well-being. Additionally, survivors felt better informed and more accepting of their illness. This approach has increased confidence and overall quality of life for many who have completed treatment.23456
Who Is on the Research Team?
Kimlin Ashing-Giwa
Principal Investigator
City of Hope Medical Center
Are You a Good Fit for This Trial?
This trial is for African American breast cancer survivors who are 1-12 months post-treatment for stage 0-3 cancer, over 18 years old, and receive care through an HMO. It's not for those with metastatic or a second primary cancer, nor for individuals with major medical conditions like severe anxiety, depression, or substance abuse issues.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive peer navigator education and ACS materials, with 4 PN sessions and a 6-month booster session
Follow-up
Participants are monitored for adherence to the SCP schedule of follow-up examinations
What Are the Treatments Tested in This Trial?
Interventions
- Peer Navigator Education
Trial Overview
The study tests if peer navigator education can improve the quality of life in these survivors. Participants will be randomly placed into groups where they'll receive educational sessions and counseling from peers to help manage their survivorship care.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants receive 4 PN sessions tailored to their needs followed by a 6 month booster session and ACS materials.
Participants receive ACS materials only.
Find a Clinic Near You
Who Is Running the Clinical Trial?
City of Hope Medical Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Published Research Related to This Trial
Citations
The Role of Peer Support and Patient Navigation for ...
Under CBO-led cancer control, empowerment was high: most survivors felt confident in (71.2%) and knowledgeable about (66.4%) managing their care.
Program Turns Cancer Survivors Into Peer Navigators
For patients, being matched with a peer navigator correlated with a decrease in trauma symptoms— most notably arousal—and improvements in emotional well-being ...
Peer Navigator Education in Improving Survivorship Care ...
Study Overview. Brief Summary. This randomized clinical trial studies peer navigator education in improving survivorship care in African American breast cancer ...
Empowerment among breast cancer survivors using an ...
The most commonly experienced empowerment outcomes were “being better informed” and “improved acceptance of the illness.” “Exchanging ...
5.
iaap-journals.onlinelibrary.wiley.com
iaap-journals.onlinelibrary.wiley.com/doi/full/10.1111/aphw.12473What works in peer support for breast cancer survivors: A ...
The aim of the present systematic review and meta-ethnography is to explore the qualitative evidence on the experience of breast cancer survivors in peer ...
Peer navigation in African American breast cancer survivors
The purpose of this study was to explore the feasibility and acceptability of a peer navigation survivorship program for African American (AA) breast cancer ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.